This page is no longer being maintained. Please visit our new site at

Ya no se mantiene esta página. Por favor visite nuestro nuevo sitio en

Medication Assisted Treatment: Clinical Decision Making
Central East ATTC

Event Type: Educational Event
What: The FDA has approved three medications for the treatment of Opioid Use Disorders (OUD's): methadone, buprenorphine and naltrexone (both oral and depot-Vivitrol). Research, science and proven practice have demonstrated that treatment for OUD's should include the use of one of these medications for most patients. The choice of which of the three medications is most appropriate for each individual is a clinical decision that is best made collaboratively by the treating physician and the patient. It is both a science and an art to help each patient select the medication that fits his/her medical and personal needs, and to select and adjust the dosage to achieve the greatest benefit for the patient.This course will provide a description of each of the three FDA approved medications Vivitrol, discuss their individual similarities and differences, and examine the factors that should be considered to decide which medication will be most appropriate for each individual client.
When: 9/19/2017;  8:30 AM To 4:00 PM
Where: Community Behavioral Health
801 Market Street, Room 1154A
Philadelphia, Pennsylvania 19107
For more information, contact: Ninette Powell - Danya Institute
Phone: 240-645-1145
Registration: Go to
Community Behavioral Health
ATTC Network Home      Treatment & Help      The ATTC Hub        Contact Us      Site Map      Copyright Information      Join Our Email List